See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech · page 32 of 39
The slide compares monotherapy (anti-PDL1, IL-12 mRNA) against combination therapy at different doses, showing a clear synergistic effect.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/6
chart 1/1 image 1/1 list 1/1 metric 0/1 title 2/2
1 without position metric 1
metric · primary
Components 6
line logo bullet primary action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1